1. Home
  2. FNV vs HLN Comparison

FNV vs HLN Comparison

Compare FNV & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franco-Nevada Corporation

FNV

Franco-Nevada Corporation

HOLD

Current Price

$231.39

Market Cap

40.1B

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$9.82

Market Cap

43.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNV
HLN
Founded
1986
2022
Country
Canada
United Kingdom
Employees
N/A
N/A
Industry
Precious Metals
Package Goods/Cosmetics
Sector
Basic Materials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
40.1B
43.7B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
FNV
HLN
Price
$231.39
$9.82
Analyst Decision
Buy
Buy
Analyst Count
8
1
Target Price
$248.13
N/A
AVG Volume (30 Days)
806.0K
7.9M
Earning Date
03-10-2026
02-26-2026
Dividend Yield
0.69%
1.86%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$36.58
$7.04
Revenue Next Year
$6.57
$4.58
P/E Ratio
$53.29
$49.05
Revenue Growth
N/A
N/A
52 Week Low
$144.76
$8.71
52 Week High
$285.67
$11.42

Technical Indicators

Market Signals
Indicator
FNV
HLN
Relative Strength Index (RSI) 40.65 38.06
Support Level $221.03 $9.59
Resistance Level $268.79 $9.96
Average True Range (ATR) 8.52 0.14
MACD -3.05 -0.05
Stochastic Oscillator 26.46 17.68

Price Performance

Historical Comparison
FNV
HLN

About FNV Franco-Nevada Corporation

Franco-Nevada Corp is a precious-metals-focused royalty and investment company. The company owns a diversified portfolio of precious metals and royalty streams, which is actively managed to generate the bulk of its revenue from gold, silver, and platinum. The company does not operate mines, develop projects, or conduct exploration. The company's short-term financial performance is linked to the price of commodities and the amount of production from its portfolio of producing assets. Its long-term performance is affected by the availability of exploration and development capital. The company holds a portfolio of assets, diversified by commodity, revenue type, and stage of a project.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: